Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: A model for analyzing the cost of the main clinical events after lung transplantation
Author: Sharples, L.
Taylor, G.
Karnon, J.
Caine, N.
Buxton, M.
McNeil, K.
Wallwork, J.
Citation: Journal of Heart and Lung Transplantation, 2001; 20(4):474-482
Publisher: Elsevier Science Inc
Issue Date: 2001
ISSN: 1053-2498
Statement of
Linda D. Sharples, Gordon J. Taylor, Jonathan Karnon, Noreen Caine, Martin Buxton, Keith McNeil and John Wallwork
Abstract: <h4>Background</h4>The aim of this project was to model clinically important events experienced by lung transplant patients (from the day after transplant to 5 years or death) and costs associated with these events, and to assess the economic impact of different immunosuppression therapies.<h4>Methods</h4>The population comprised 356 lung transplant patients (223 heart-lung, 102 single lung and 31 double lung) transplanted between April 1984 and December 1997. All patients received a cyclosporine-based triple-immunosuppression protocol. We designed a Markov model that included 3 time periods (0 to 6, 7 to 12, and 13 to 60 months), 5 clinical states (well, acute rejection, cytomegalovirus infection, non-cytomegalovirus infection and bronchiolitis obliterans syndrome), and death. For the well state, cost elements were immunosuppression, prophylaxis, and routine clinic visits. For all other states, cost elements were diagnosis, treatment, and bed days/visits. We excluded costs of the procedure.<h4>Results</h4>The monthly costs associated with the well state decreased over time, from pound sterlings 1,778 ($2,658) in the first 6 months to pound sterlings 503 ($752) in months 7 to 12 and pound sterlings 350 ($523) after the first 12 months. The cost per event of the acute states remained reasonably constant over the 3 periods: pound sterlings 1,850 ($2,766) for rejection, pound sterlings 3,380 ($5,053) for cytomegalovirus, and pound sterlings 2,790 ($4,171) for other infections. The average cost per patient, discounted at 6%, over 5 years was pound sterlings 35,429 ($52,966) (95% range, pound1,435 [$2,145] to pound67,079 [$100,283]). This estimate is most sensitive to changes in immunosuppression. Substituting tacrolimus for cyclosporine increased 5-year costs by 5%; substituting mycophenolate mofetil for azathioprine increased 5-year costs by 26%.<h4>Conclusions</h4>This model is valuable in estimating the effect of new immunosuppression agents on the costs of follow-up care.
Keywords: Humans
Immunosuppressive Agents
Lung Transplantation
Models, Economic
Monte Carlo Method
Markov Chains
Sensitivity and Specificity
Survival Analysis
Prospective Studies
Health Care Costs
Description: Copyright © 2001 International Society for Heart and Lung Transplantation. Published by Elsevier Science Inc.
DOI: 10.1016/S1053-2498(00)00251-5
Description (link):
Published version:
Appears in Collections:Aurora harvest 6
Public Health publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.